News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Scancell Enters Research Collaboration With immatics biotechnologies GmbH To Develop Novel Immunobody(R) Vaccines For Colorectal Cancer


6/29/2010 7:44:45 AM

NOTTINGHAM, UK--(BUSINESS WIRE)--Scancell Holdings Plc, (PLUS:SCLP), the developer of therapeutic cancer vaccines, today announces a research collaboration with immatics biotechnologies GmbH (“immatics”) to explore the development of novel ImmunoBody® vaccines for colorectal cancer.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES